News | July 20, 2001

CB and Medtower partner to provide in-depth medical information during clinical trials

CB Technologies, Inc., the premier provider of technology tools and services to life science companies, and Medtower, Inc., recently announced their partnership to integrate Medtower's Life Science Informationists Service and custom-tailored disease-specific database services into CB's myMetaTrial Management Portal. Through this integration, users of myMetaTrial will be able to obtain customized answers to their specific questions regarding therapeutic areas, diseases, procedures, and more.

CB's myMetaTrial Management Portal is a customizable clinical portal that provides easy access to information across one or more clinical trials. Study sponsors can track their entire portfolio of trials through myMetaTrial or review the progress of a single study. The portal gives other parties involved in the trial-investigators, monitors, project managers-access to a wide array of information and tools to better manage clinical trials, including MetaTrial electronic data capture (EDC) software, document sharing, trial management reporting, and threaded discussions among others. Access to trial information can be customized for each user.

Medtower's Informationists are specialists (M.D.s and Ph.D.s) who understand the information needs of the life science industry and can tap the best academic thought leaders internationally to answer specific medical, biotechnology and pharmaceutical questions. Informationists retrieve, analyze, and process questions from users and then generate customized knowledge reports answering users' questions. By integrating Medtower's Informationists services and disease-specific databases into myMetaTrial, users will have access to vast amounts of medical information without having to sort through Internet search results or databases.

"The need for validated life science information that is readily accessible will continue to grow especially with the increase in clinical trials occurring in the foreseeable future. It is within this context that Medtower will be able to help meet the exact needs of CB Technologies' clients by giving them access to not only our stored clinical content but access to our academic medical experts to answer their specific life science questions," said Stephen Sun, MD, Chief Executive Officer of Medtower. "We are pleased to be in a partnership that will greatly introduce our products and services to a previously untapped area within the drug discovery process."

"CB is very pleased to offer Medtower's services to our Portal clients," said Anne Zielinski, CB's vice president, strategic alliances. "Easy access to information has always been the hallmark of our Portal, and through Medtower we are able to deepen the pool of clinical information that our clients are able to access."

About CB Technologies
CB Technologies is a leading provider of Electronic Clinical Intelligence tools and services for the life science industries. CB is headquartered in Philadelphia with offices in Boston, New York, Charleston, San Francisco, San Diego and London. For more information visit www.cbtech.com or www.metatrial.com .

About Medtower, Inc.
Medtower is a medical knowledge and technology company that provides both an Internet-based information portal and a unique, customized service for handling complex questions in the life science industry.

Source: CB Technologies, Inc.

Subscribe to our free e-mail newsletter.

Click for a free Buyer's Guide listing.